IRF2BP2: A new player in the regulation of cell homeostasis

IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid

(2018) Samir Mazharuddin et al.   LEUKEMIA & LYMPHOMA

BCR-ABL1 -like acute lymphoblastic leukaemia: From bench to bedside

(2017) Judith M. Boer et al.   EUROPEAN JOURNAL OF CANCER

Loss of IRF2BP2 in Microglia Increases Inflammation and Functional Deficits after Focal Ischemic Brain Injury

(2017) Shelly A. Cruz et al.   Frontiers in Cellular Neuroscience

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

(2017) Angel Garcia-Diaz et al.   Cell Reports

IRF2BP2-deficient microglia block the anxiolytic effect of enhanced postnatal care

(2017) Aswin Hari et al.   Scientific Reports

New variant of acute promyelocytic leukemia withIRF2BP2-RARAfusion

(2016) Yoshimitsu Shimomura et al.   CANCER SCIENCE

Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder

(2016) Michael D. Keller et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IRF2BP2 transcriptional repressor restrains naive CD4 T cell activation and clonal expansion induced by TCR triggering

(2016) Cristiane Sécca et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemia

(2016) J V Jovanovic et al.   LEUKEMIA

Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity

(2016) R. D. Dorand et al.   SCIENCE

IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to AtherosclerosisNovelty and Significance

(2015) Hsiao-Huei Chen et al.   CIRCULATION RESEARCH

Identification of a Novel Fusion Gene,IRF2BP2-RARA, in Acute Promyelocytic Leukemia

(2015) C. Cameron Yin et al.   Journal of the National Comprehensive Cancer Network

Control of developmentally primed erythroid genes by combinatorial co-repressor actions

(2015) Ralph Stadhouders et al.   Nature Communications

Mutational analysis of primary central nervous system lymphoma

(2015) Aurélie Bruno et al.   Oncotarget

Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients

(2014) L C M Arruda et al.   BONE MARROW TRANSPLANTATION

PD-1 blockade induces responses by inhibiting adaptive immune resistance

(2014) Paul C. Tumeh et al.   NATURE

Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma

(2014) IOANNIS PANAGOPOULOS et al.   ONCOLOGY REPORTS

PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells

(2014) Hatem Soliman et al.   PLoS One

Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics

(2013) Linn Fagerberg et al.   MOLECULAR & CELLULAR PROTEOMICS

Whole-Transcriptome Sequencing Identifies Novel IRF2BP2-CDX1 Fusion Gene Brought about by Translocation t(1;5)(q42;q32) in Mesenchymal Chondrosarcoma

(2012) Kaja B. Nyquist et al.   PLoS One

A Novel Transcription Complex That Selectively Modulates Apoptosis of Breast Cancer Cells through Regulation of FASTKD2

(2011) K. T. Yeung et al.   MOLECULAR AND CELLULAR BIOLOGY

Interferon Regulatory Factor 2 Binding Protein 2 Is a New NFAT1 Partner and Represses Its Transcriptional Activity

(2011) F. R. G. Carneiro et al.   MOLECULAR AND CELLULAR BIOLOGY

Identification of a Phosphorylation-Dependent Nuclear Localization Motif in Interferon Regulatory Factor 2 Binding Protein 2

(2011) Allen C. T. Teng et al.   PLoS One

IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression

(2010) Allen C. T. Teng et al.   FASEB JOURNAL

The mechanism of eukaryotic translation initiation and principles of its regulation

(2010) Richard J. Jackson et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance

(2009) S. Blotta et al.   BLOOD

Identification of a Novel Pathway That Selectively Modulates Apoptosis of Breast Cancer Cells

(2009) Alexander A. Tinnikov et al.   CANCER RESEARCH

The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response

(2008) Max Koeppel et al.   NUCLEIC ACIDS RESEARCH